HDAC6 degrader-4
HDAC6 degrader-4 is a PROTAC and a selective HDAC6 degrader consists of a non-selective HDAC inhibitor and thalidomide-type E3 ligase ligand. HDAC6 degrader-4 can be used for cancer research[1].
Product Specifications
CAS Number
2235382-05-3
UNSPSC
12352005
Target
HDAC; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac6-degrader-4.html
Solubility
10 mM in DMSO
Smiles
O=C(NO)CCCCCCC(N/N=C/C1=CC=C(OCCOCCOCCN2N=NC(CNC3=CC=CC(C(N4C(CC5)C(NC5=O)=O)=O)=C3C4=O)=C2)C=C1)=O
Molecular Formula
C37H45N9O10
Molecular Weight
775.81
References & Citations
[1]Yang K, et al. Development of the first small molecule histone deacetylase 6 (HDAC6) degraders. Bioorg Med Chem Lett. 2018 Aug 1;28 (14) :2493-2497.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC-16462-01 50 μL
Recombinant Ubiquitin Conjugating Enzyme E2 A/B Antibody
Sign In for Pricing
View Details RC-16462-02 100 µL
Recombinant Ubiquitin Conjugating Enzyme E2 A/B Antibody
Sign In for Pricing
View Details RC-16462-03 1 mL
Recombinant Ubiquitin Conjugating Enzyme E2 A/B Antibody
Sign In for Pricing
View Details 
BNC700485-500 1x 500 µL
ODC-1 (Ornithine Decarboxylase-1) (ODC1/485), CF770 conjugate, 0.1mg/mL
Sign In for Pricing
View Details